...
首页> 外文期刊>The FASEB Journal >Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability
【24h】

Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability

机译:控制新生高密度脂蛋白颗粒异质性的因素:ATP结合盒转运蛋白A1活性以及细胞脂质和载脂蛋白AI的利用率

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Nascent high-density lipoprotein (HDL) particles arise in different sizes. We have sought to uncover factors that control this size heterogeneity. Gel filtration, native PAGE, and protein cross-linking were used to analyze the size heterogeneity of nascent HDL produced by BHK-ABCA1, RAW 264.7, J774, and HepG2 cells under different levels of two factors considered as a ratio, the availability of apolipoprotein AI (apoAI) -accessible cell lipid, and concentration of extracellular lipid-free apoAI. Increases in the available cell lipid:apoAI ratio due to either elevated ATP-binding cassette transporter A1 (ABCA1) expression and activity or raised cell density (i.e., increasing numerator) shifted the production of nascent HDL from smaller particles with fewer apoAI molecules per particle and fewer molecules of choline-phospholipid and cholesterol per apoAI molecule to larger particles that contained more apoAI and more lipid per molecule of apoAI. A further shift to larger particles was observed in BHK-ABCA1 cells when the available cell lipid:apoAI ratio was raised still higher by decreasing the apoAI concentration (i.e., the denominator). These changes in nascent HDL biogenesis were reminiscent of the transition that occurs in the size composition of reconstituted HDL in response to an increasing initial lipid:apoAI molar ratio. Thus, the ratio of available cell lipid:apoAI is a fundamental cause of nascent HDL size heterogeneity, and rHDL formation is a good model of nascent HDL biogenesis.—Lyssenko, N. N., Nickel, M., Tang, C., Phillips, M. C. Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability.
机译:新生的高密度脂蛋白(HDL)颗粒的大小不同。我们试图发现控制这种大小异质性的因素。使用凝胶过滤,天然PAGE和蛋白质交联来分析BHK-ABCA1,RAW 264.7,J774和HepG2细胞在不同水平的两个因素(载脂蛋白的利用率)下产生的新生HDL的大小异质性AI(apoAI)-可及的细胞脂质,以及细胞外无脂质apoAI的浓度。 ATP结合盒转运蛋白A1(ABCA1)的表达和活性升高或细胞密度提高(即分子增加)导致可利用的细胞脂质:apoAI比率增加,从而使新生的HDL的生产从较小的颗粒转移,每个颗粒较少的apoAI分子每个apoAI分子中的胆碱磷脂和胆固醇分子更少,而每个apoAI分子中包含更多apoAI和更多脂质的较大颗粒。当通过降低apoAI的浓度(即分母)使可用的细胞脂质:apoAI的比例进一步提高时,在BHK-ABCA1细胞中观察到进一步向更大的颗粒转移。新生HDL生物发生的这些变化使人联想到响应于初始脂质:apoAI摩尔比的增加,重构的HDL的大小组成中发生的过渡。因此,可用细胞脂质:apoAI的比率是新生的HDL大小异质性的根本原因,而rHDL的形成是新生的HDL生物发生的良好模型。—Lyssenko,NN,Nickel,M.,Tang,C.,Phillips,MC控制新生高密度脂蛋白颗粒异质性的因素:ATP结合盒转运蛋白A1活性以及细胞脂质和载脂蛋白AI的利用率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号